Indivior Pharmaceuticals Inc. (INDV) vs Lantheus Holdings, Inc. (LNTH)
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
- Lantheus Holdings, Inc. LNTH 99.70 −0.29%
Indivior Pharmaceuticals Inc. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. is the larger, with a market value of $6.5B against $4.0B — 1.6× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 11.2× against 23.7×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 13.5% against 2.35%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 17.7%) and the higher return on invested capital (460.5% vs 14.7%). Across the 19 metrics below, Indivior Pharmaceuticals Inc. leads on 14 and Lantheus Holdings, Inc. on 5.
Valuation
Profitability
| Metric | INDV | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 81.97% | 60.14% | 53.94% |
| Operating margin | 31.56% | 19.43% | 0.00% |
| Net margin | 26.75% | 17.69% | 0.00% |
| Free cash flow margin | (8.34%) | 25.24% | 0.00% |
| Return on equity | (153.12%) | 22.21% | (0.40%) |
| Return on assets | 26.52% | 12.15% | (3.32%) |
| Return on invested capital | 460.53% | 14.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack